Decoy Therapeutics, Inc. (DCOY) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$1.19

From 52W high−97.63%

Volume56627.00

Market cap$2.79M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataOct 19, 2026

Open

$1.19

From 52W high

−97.63%

Volume

56627.00

Market cap

$2.79M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.4x

P/E (TTM)

—

RSI (14)

27.2

MomentumView details →

1D Return

+0.00%

YTD Return

−85.11%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

0.4x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

0.6x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−334.41%

ROA (TTM)

−160.53%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

+48.31%

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

+70.10%

EBITDA YoY

—

MomentumView details →

1D Return

+0.00%

YTD Return

−85.11%

1Y Return

−97.61%

RSI (14)

27.2

vs 50D SMA

−55.66%

vs 200D SMA

−80.34%

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.83x

Quick Ratio

1.83x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$4.46

EPS Surprise

−54.86%

Beats (12Q)

7/12

Next Q EPS Est

−$1.11

Avg Surprise (4Q)

29.47%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−14.45M

Op. CF (TTM)

−8.32M

Next earningsNov 13, 2026 →

Latest newsMore news →

Decoy Therapeutics reported preclinical pharmacokinetic data showing that a single intranasal dose of its DCOY-CoV program candidate sustains drug levels above designed therapeutic concentrations for up to 7 days in nasal mucosal and lung tissue.21d ago

Decoy Therapeutics Inc. entered a warrant inducement agreement under which a holder exercised 1,184,434 Series B Milestone Warrants at a reduced price of $3.25 per share for gross proceeds of about $3.85 million, and the company issued new unregistered warrants to purchase up to 2,368,868 shares at $3.25 per share.26d ago

Similar companies

Mustang Bio, Inc.MBIO HCW Biologics Inc.HCWB BioAtla, Inc.BCAB Aptevo Therapeutics Inc.APVO 60 Degrees Pharmaceuticals, Inc.SXTP Affimed N.V.AFMD Find similar companies →

Latest newsMore news →

Decoy Therapeutics reported preclinical pharmacokinetic data showing that a single intranasal dose of its DCOY-CoV program candidate sustains drug levels above designed therapeutic concentrations for up to 7 days in nasal mucosal and lung tissue.21d ago Decoy Therapeutics Inc. entered a warrant inducement agreement under which a holder exercised 1,184,434 Series B Milestone Warrants at a reduced price of $3.25 per share for gross proceeds of about $3.85 million, and the company issued new unregistered warrants to purchase up to 2,368,868 shares at $3.25 per share.26d ago